User:Mr. Ibrahem/Nimodipine

Nimodipine, sold under the brand name Nimotop among others, is a medication used to prevent vasospasm secondary to subarachnoid hemorrhage. It is taken by mouth or by injection into a vein. Onset is rapid with a duration of action of 4 hours.

Common side effects include low blood pressure and headache. Other side effects may include slow heart rate, ileus, and low platelets. Safety in pregnancy is unclear. It is a calcium channel blocker of the dihydropyridine type.

Nimodipine was patented in 1971 and approved for medical use in Germany in 1985. It was approved in the United States in 1988. In the United Kingdom 100 tablets of 30 mg costs the NHS about £40. This amount in the United States costs about 170 USD.